Frequently Asked Questions
The market is segmented based on Segmentation, By Drug Type (Anaesthetics, Antibiotics, Pain Relief Drugs, Calcium Supplements, Vasoconstrictors, Antihistamines, and Others), Dosage Form (Nasal Spray, Nasal Drops, Nasal Gels and Ointments, Nasal Powders, and Others), Container Type (Non-Pressurized Containers and Pressurized Containers), System Type (Multi-Dose, Bi-Dose, and Unit Dose), Therapeutic Application (Allergic and Non-Allergic Rhinitis, Nasal Congestion, Asthma, Vaccination, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), End User (Hospitals, Clinics, and Home Care Settings) – Industry Trends and Forecast to 2031.
.
The Global Nasal Drug Delivery Market size was valued at USD 65.42 USD Million in 2023.
The Global Nasal Drug Delivery Market is projected to grow at a CAGR of 6.9% during the forecast period of 2024 to 2031.
The major players operating in the market include Merck & Co,GlaxoSmithKline,AstraZeneca,Johnson & Johnson,Mystic Pharmaceuticals,Bausch Health Companies ,BD,3M,AptarGroup ,OptiNose US ,Dr. Reddy’s Laboratories Ltd,Flo Nasal Products,Cadila Pharmaceuticals,PendoPharm ,Neurelis .
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
